½ÃÀ庸°í¼­
»óǰÄÚµå
1592916

¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çü, ÀûÀÀÁõ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Infusion Pump Software Market by Type (Alarm & Alert Management Software, Dose Rate Control Software, Interoperability Software), Indication (Anesthesia, Antibiotics, Chemotherapy), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023³â¿¡ 9¾ï 8,344¸¸ USD·Î Æò°¡µÇ°í, 2024³â¿¡´Â 10¾ï 5,060¸¸ USD¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.09%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 15¾ï 8,922¸¸ USD·Î µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î´Â ±¤¹üÀ§ÇÑ ÀÇ·á±â±â ½ÃÀå¿¡¼­ Áß¿äÇÑ ±â¼ú ºÎ¹®À» Çü¼ºÇϰí ȯÀÚÀÇ Ã¼³»¿¡ ÁÖÀÔ, Åõ¾à ¹× ¿µ¾ç¼Ò ÁÖÀÔÀ» Á¤¹ÐÇÏ°í ¾ÈÁ¤ÀûÀ¸·Î Á¦¾îÇÏ°í ¸ð´ÏÅ͸µÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¸¸¼º Áúȯ Áõ°¡, ÀçÅà °Ç°­ °ü¸® ¼ö¿ä, °í·ÉÈ­ Àα¸ Áõ°¡¿¡ ÀÇÇØ È¿À²ÀûÀÌ°í ½Ç¼ö°¡ ¾ø´Â Åõ¾à °ü¸® ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ¸¦ Æ÷ÇÔ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ÇコÄÉ¾î ±â¼úÀÇ Áøº¸, ±ÔÁ¦ ´ç±¹ÀÇ Àΰ¡ Áõ°¡, ÇコÄÉ¾î ±â±â¿¡ À־ÀÇ ¹«¼± Á¢¼Ó°ú ½º¸¶Æ®Æù ÅëÇÕ ¼ö¿ä Áõ°¡°¡ ÀÖ½À´Ï´Ù. ¾ß¾Ï µî ¸¸¼ºÁúȯ ȯÀÚÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí Áö¼ÓÀûÀÎ ¾àÁ¦ ÁÖÀÔÀÌ ÇÊ¿äÇÏ´Ù´Â °ÍÀ» µé ¼ö ÀÖ½À´Ï´Ù. Å« ºñÁî´Ï½º ±âȸ¸¦ °¡Á®´Ù ±â¾÷Àº µ¥ÀÌÅÍ À¯ÃâÀ» ÁÙÀ̰í ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ °­·ÂÇÑ »çÀ̹ö º¸¾È ´ëÃ¥À» °®Ãá »ç¿ëÇϱ⠽±°í ±â´ÉÀÌ Ç³ºÎÇÑ ¼ÒÇÁÆ®¿þ¾î °³¹ß¿¡ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù. ¼ºÀåÀº °íµµ ÁÖÀÔ ÆßÇÁÀÇ °íºñ¿ë, º¹ÀâÇÑ ±ÔÁ¦ ¿ä±¸ »çÇ× ¹× »óÈ£ ¿î¿ë¼º ¹®Á¦¿Í °°Àº Á¦¾à¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. °ú ±â¼ú Çõ½Å ¸ñÇ¥´Â ÀΰøÁö´É°ú ¸Ó½Å·¯´×À» ÅëÇÕÇÏ¿© ¿¹Ãø À¯Áö º¸¼ö¸¦ °­È­Çϰí ȯÀÚ °ü¸®¸¦ °³º°È­ÇÏ´Â °ÍÀÔ´Ï´Ù. ¿¡ ÁßÁ¡À»µÎ¸é¼­ ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ» °­È­Çϱâ À§ÇØ ³ë·Â ±âÁ¸ÀÇ ÇѰ踦 ÇØ°áÇÏ°í »õ·Î¿î ±â¼úÀû ÇÁ·ÐƼ¾î¸¦ °³Ã´ÇÏ´Â Àü·«Àû Á¢±Ù¹ýÀ» äÅÃÇÔÀ¸·Î½á ±â¾÷Àº ÁøÈ­ÇÏ´Â ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾îÀÇ Àü¸Á ¼Ó¿¡¼­ ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÕ´Ï´Ù. ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 9¾ï 8,344¸¸ ´Þ·¯
¿¹Ãø³â(2024) 10¾ï 5,060¸¸ ´Þ·¯
¿¹Ãø³â(2030) 15¾ï 8,922¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.09%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. È­¿Í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÏ´Â °Í ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °í·ÉÀÚ Àα¸ Áõ°¡¿¡ ¼ö¹ÝÇÏ´Â ¸¸¼º ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½Â
    • ¼ö¼ú °Ç¼ö Áõ°¡ °æÇâ
    • ¿Ü·¡¿ë ÁÖÀÔ ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿ø°ÝÁöÀÇ º´¿ø¿¡ À־ÀÇ ¹«¼± Á¢¼ÓÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • °í±Þ ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾îÀÇ ÃâÇö
    • ÀçÅà ÁÖÀÔ ½Ã½ºÅÛ ¼ÒÇÁÆ®¿þ¾î Ãâ½Ã¸¦ À§ÇÑ Áö¼ÓÀûÀÎ R&D Ȱµ¿
  • ½ÃÀåÀÇ °úÁ¦
    • ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾îÀÇ ½É°¢ÇÑ Á¦Ç° ¸®ÄÝ

Porter's Five Forces : ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ Á¦°ø PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Î ¿¹»óÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ÁúȯÀÇ ¹ßº´·ü »ó½Â°ú ³ëÀÎ Àα¸ Áõ°¡
      • ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡ °æÇâ
      • ÈÞ´ëÇü ÁÖÀÔ ÆßÇÁ ¼ö¿ä Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¿ø°ÝÁöÀÇ º´¿ø¿¡ À־ÀÇ ¹«¼± Á¢¼ÓÀÇ ºÎÁ·
    • ±âȸ
      • ÷´Ü ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾îÀÇ ÃâÇö
      • ÀçÅà ÁÖÀÔ ½Ã½ºÅÛ ¼ÒÇÁÆ®¿þ¾îÀÇ ¹ß¸Å¸¦ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß Ȱµ¿
    • °úÁ¦
      • ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾îÀÇ Áß¿äÇÑ Á¦Ç° ¸®ÄÝ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°

  • ¾Ë¶÷ ¹× °æº¸ °ü¸® ¼ÒÇÁÆ®¿þ¾î
  • ¼±·®·ü Á¦¾î ¼ÒÇÁÆ®¿þ¾î
  • »óÈ£ ¿î¿ë¼º ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÀûÀÀÁõº°

  • ¸¶Ãë
  • Ç×»ýÁ¦
  • È­Çпä¹ý
  • ¿µ¾ç Áö¿ø
  • ÅëÁõ °ü¸®

Á¦8Àå ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • ÀçÅà ÇコÄɾî
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖÀÔ ÆßÇÁ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Agilent Technologies, Inc.
  • B. Braun Medical Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cane SpA
  • Cerner Corporation
  • Eitan Medical Ltd.
  • F. Hoffmann-La Roche AG
  • FLOWONIX MEDICAL INC
  • Fresenius Kabi Canada Ltd.
  • ICU Medical, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Micrel Medical Devices SA
  • Moog Inc.
  • Novo Nordisk A/S
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Teleflex Incorporated
  • Terumo Corporation
  • Ypsomed AG
  • ZOLL Medical Corporation
  • Zyno Medical
BJH 24.11.26

The Infusion Pump Software Market was valued at USD 983.44 million in 2023, expected to reach USD 1,050.60 million in 2024, and is projected to grow at a CAGR of 7.09%, to USD 1,589.22 million by 2030.

Infusion pump software forms a critical technology segment within the broader medical devices market, designed to control and monitor the infusion of fluids, medication, or nutrients into a patient's body with precision and reliability. Necessity arises from the increasing prevalence of chronic diseases, demand for home healthcare, and the growing aging population, driving the need for efficient and error-free medication administration systems. The application scope of infusion pump software spans hospitals, ambulatory care settings, and home-care environments, with end-users including medical professionals and patients. Market growth is largely fueled by advancements in healthcare technology, increased regulatory approvals, and the rising demand for wireless connectivity and smartphone integration in healthcare devices. Key influencing growth factors include the increasing burden of chronic diseases such as diabetes and cancer, necessitating continuous drug infusion. The emergence of smart infusion pumps, which offer enhanced usability and safety features like drug libraries and dose error reduction systems, presents significant opportunities. Companies are urged to focus on the development of user-friendly, feature-rich software with robust cybersecurity measures to mitigate data breaches and ensure patient safety. However, market growth faces limitations such as high costs of advanced infusion pumps, complex regulatory requirements, and interoperability challenges. Addressing these involves leveraging cloud-based solutions for real-time monitoring and data management, which could reduce costs and improve accessibility while enhancing functional features. Research and innovation should target integrating artificial intelligence and machine learning to enhance predictive maintenance and personalize patient care. The market is characterized by competitive dynamics with both established players and innovative startups striving to enhance software capabilities, focusing on safety, accuracy, and user-friendliness. By adopting a strategic approach towards addressing existing limitations and exploring new technological frontiers, businesses can harness opportunities within the evolving landscape of infusion pump software.

KEY MARKET STATISTICS
Base Year [2023] USD 983.44 million
Estimated Year [2024] USD 1,050.60 million
Forecast Year [2030] USD 1,589.22 million
CAGR (%) 7.09%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infusion Pump Software Market

The Infusion Pump Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of chronic diseases coupled with growth in the geriatric population
    • Increasing trend in the number of surgical procedures performed
    • Growing demand for ambulatory infusion pumps
  • Market Restraints
    • Lack of wireless connectivity in remote hospitals
  • Market Opportunities
    • Emergence of advanced infusion pump software
    • Ongoing R&D activities to launch home infusion systems software
  • Market Challenges
    • Significant product recalls of infusion pump software

Porter's Five Forces: A Strategic Tool for Navigating the Infusion Pump Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infusion Pump Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infusion Pump Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infusion Pump Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infusion Pump Software Market

A detailed market share analysis in the Infusion Pump Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infusion Pump Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infusion Pump Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infusion Pump Software Market

A strategic analysis of the Infusion Pump Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infusion Pump Software Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., B. Braun Medical Inc., Baxter International, Inc., Becton, Dickinson and Company, Cane S.p.A., Cerner Corporation, Eitan Medical Ltd., F. Hoffmann-La Roche AG, FLOWONIX MEDICAL INC, Fresenius Kabi Canada Ltd., ICU Medical, Inc., Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Novo Nordisk A/S, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Teleflex Incorporated, Terumo Corporation, Ypsomed AG, ZOLL Medical Corporation, and Zyno Medical.

Market Segmentation & Coverage

This research report categorizes the Infusion Pump Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Alarm & Alert Management Software, Dose Rate Control Software, and Interoperability Software.
  • Based on Indication, market is studied across Anesthesia, Antibiotics, Chemotherapy, Nutritional Support, and Pain Management.
  • Based on End-User, market is studied across Ambulatory Care Centers, Home Healthcare, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic diseases coupled with growth in the geriatric population
      • 5.1.1.2. Increasing trend in the number of surgical procedures performed
      • 5.1.1.3. Growing demand for ambulatory infusion pumps
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of wireless connectivity in remote hospitals
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced infusion pump software
      • 5.1.3.2. Ongoing R&D activities to launch home infusion systems software
    • 5.1.4. Challenges
      • 5.1.4.1. Significant product recalls of infusion pump software
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infusion Pump Software Market, by Type

  • 6.1. Introduction
  • 6.2. Alarm & Alert Management Software
  • 6.3. Dose Rate Control Software
  • 6.4. Interoperability Software

7. Infusion Pump Software Market, by Indication

  • 7.1. Introduction
  • 7.2. Anesthesia
  • 7.3. Antibiotics
  • 7.4. Chemotherapy
  • 7.5. Nutritional Support
  • 7.6. Pain Management

8. Infusion Pump Software Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Home Healthcare
  • 8.4. Hospitals & Clinics

9. Americas Infusion Pump Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infusion Pump Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infusion Pump Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. B. Braun Medical Inc.
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Cane S.p.A.
  • 6. Cerner Corporation
  • 7. Eitan Medical Ltd.
  • 8. F. Hoffmann-La Roche AG
  • 9. FLOWONIX MEDICAL INC
  • 10. Fresenius Kabi Canada Ltd.
  • 11. ICU Medical, Inc.
  • 12. Medtronic PLC
  • 13. Merck KGaA
  • 14. Micrel Medical Devices SA
  • 15. Moog Inc.
  • 16. Novo Nordisk A/S
  • 17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • 18. Teleflex Incorporated
  • 19. Terumo Corporation
  • 20. Ypsomed AG
  • 21. ZOLL Medical Corporation
  • 22. Zyno Medical
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦